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Due to the implementation of the Montreal Protocol, which has limited, and is now probably reversing,
the depletion of the stratospheric ozone layer, only modest increases in solar UV-B radiation at the
surface of the Earth have occurred. For many fair-skinned populations, changing behaviour with regard to
exposure to the sun over the past half century – more time in the sun, less clothing cover (more skin
exposed), and preference for a tan – has probably contributed more to greater levels of exposure to UV-B
radiation than ozone depletion. Exposure to UV-B radiation has both adverse and beneﬁcial eﬀects on
human health. This report focuses on an assessment of the evidence regarding these outcomes that has
been published since our previous report in 2010. The skin and eyes are the organs exposed to solar UV
radiation. Excessive solar irradiation causes skin cancer, including cutaneous malignant melanoma and
the non-melanoma skin cancers, basal cell carcinoma and squamous cell carcinoma, and contributes to
the development of other rare skin cancers such as Merkel cell carcinoma. Although the incidence of
melanoma continues to increase in many countries, in some locations, primarily those with strong sun
protection programmes, incidence has stabilised or decreased over the past 5 years, particularly in
younger age-groups. However, the incidence of non-melanoma skin cancers is still increasing in most
locations. Exposure of the skin to the sun also induces systemic immune suppression that may have
adverse eﬀects on health, such as through the reactivation of latent viral infections, but also beneﬁcial
eﬀects through suppression of autoimmune reactivity. Solar UV-B radiation damages the eyes, causing
cataracts and pterygium. UV-B irradiation of the skin is the main source of vitamin D in many geographic
locations. Vitamin D plays a critical role in the maintenance of calcium homeostasis in the body; severe
deﬁciency causes the bone diseases, rickets in children and osteomalacia in adults. Although many
studies have implicated vitamin D deﬁciency in a wide range of diseases, such as cancer and cardio-
vascular disease, more recent evidence is less compelling, with meta-analyses of supplementation trials
failing to show a beneﬁcial eﬀect on the health outcomes that have been tested. It continues to be
diﬃcult to provide public health messages to guide safe exposure to the sun that are accurate, simple,
and can be used by people with diﬀerent skin types, in diﬀerent locations, and for diﬀerent times of the
year or day. There is increasing interest in relating sun protection messages to the UV Index. Current sun
protection strategies are outlined and assessed. Climatic factors aﬀect the amount of UV radiation
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received by the skin and eyes, separately from the eﬀect of ozone depletion. For example, cloud cover
can decrease or increase the intensity of UV radiation at Earth’s surface and warmer temperatures and
changes in precipitation patterns may alter the amount of time people spend outdoors and their choice
of clothing. The combination of changes in climate and UV radiation may aﬀect the number of patho-
genic microorganisms in surface waters, and could have an impact on food security through eﬀects on
plant and aquatic systems. It remains diﬃcult to quantify these eﬀects and their possible importance for
human health.
Introduction
Stratospheric ozone limits the amount of biologically damag-
ing UV radiation in the UV-B waveband (280–315 nm) that
reaches the Earth’s surface – a 1000-fold reduction in muta-
genic UV radiation.1 Depletion of the ozone layer results in
greater potential exposure to UV-B radiation, while, for
humans, actual exposure also depends on their behaviour,
such as time spent outdoors, use of shade, and wearing of sun
protective clothing. Global climate change is altering the recov-
ery of the stratospheric ozone layer and, through eﬀects on
cloud cover, will modify the levels of UV radiation at Earth’s
surface (for detail, see Bais et al.2). Loss of snow cover will
decrease albedo in mountain regions, possibly reducing UV
radiation incident on body surfaces. Changing climate may
also alter human behaviour with regard to exposure to the
sun. Warmer temperatures may accelerate the genesis of skin
cancer and vitamin D production. In the following sections, we
assess the health risks associated with ozone depletion,
focussing on eﬀects related to UV radiation in the UV-B wave-
lengths. In addition, the risks and benefits of changing per-
sonal exposure to UV radiation under the combined eﬀects of
ozone depletion and global climate change are considered.
Eﬀects of solar UV radiation on the
skin
Human skin comprises an outer thin epidermis of about 10
cell layers and typically <100 μm deep and an inner layer, the
dermis, that consists mainly of connective tissue and gives
skin its mechanical properties. Epidermal cells are mostly
keratinocytes, with melanocytes in the basal layer producing
melanin that determines pigmentation of the skin. UV radi-
ation is absorbed in the skin by specific molecules called chro-
mophores, with the ensuing chemical changes initiating
multiple biological processes. UV-A radiation (315–400 nm)
penetrates the skin to a greater depth (into the dermis) than
UV-B radiation. Exposure to solar UV radiation may cause skin
cancer and photo-ageing, but also initiates the synthesis of
vitamin D, which is critical for human health.
Skin cancer
Solar UV radiation is the major environmental risk factor for
both melanoma and non-melanoma skin cancers (NMSCs).3
Cutaneous malignant melanoma (CMM) is the least common
of the skin cancers, but accounts for most deaths due to skin
cancer. NMSCs include basal cell carcinoma (BCC), squamous
cell carcinoma (SCC), and other rarer skin cancers. BCC occurs
approximately 3–4 times more frequently than SCC. It has the
lowest mortality rate but can cause significant ill-health due to
extensive local invasion, particularly when it arises on the face.
It is diﬃcult to assess whether, or to what level, alterations
in ozone or climate have contributed to the rising incidence of
skin cancer globally. Over the 20th century, increasing travel to
sunny locations and changed styles of clothing, at least in
some populations, have led to higher personal exposure to the
sun. This has probably been a more important driver of the
increasing incidence of skin cancer than changes in ozone or
climate.4 Changes in the diagnostic criteria for skin cancers,
including the use of dermoscopy or epiluminescent
microscopy and molecular classification,5 a lack of accurate
recording of lesions, and a more general growing awareness of
skin cancer and conservatism (erring on the safe side) in diag-
noses,6 may also have introduced temporal biases in some
instances.
Cutaneous malignant melanoma
Geographic variation and temporal trends in incidence and
mortality. World-wide, it is estimated that there were around
230 000 new cases of CMM and 55 000 deaths in 2012.7 The
incidence varies widely from country to country (Table 1), with
the highest age-standardised annual incidence rates (∼35 per
100 000 population in 2012) in Australia and New Zealand.7
CMM is rare in darker skinned populations, such as in South
Asia.8
The incidence of CMM in fair-skinned populations has
approximately doubled every 10–20 years since the 1960s and
this trend is projected to continue for at least 20 more years9
(Table 1).
The rise in incidence of CMM has been attributed to
changes in recreational behaviour leading to increased
exposure to the sun.12 The incidence rate has stabilised or is
decreasing in younger age groups (<44 years) in some
countries, such as Australia,9 but continues to increase else-
where.13,14 Public health campaigns to encourage protection
from the sun, beginning in the 1980s, have probably contribu-
ted to the decrease in incidence in younger age groups in
Australia.15
Although CMM accounts for only 4% of all skin cancer
cases, it is responsible for about 80% of deaths from skin
cancer.9 Mortality due to CMM is increasing in Southern and
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Eastern Europe,16,17 particularly in elderly men who tend to
have thicker lesions that are more invasive and less likely than
the thinner lesions to respond to treatment.18 Here, the
increase in deaths is probably due to the rising incidence
of CMM. Mortality due to CMM is stable or decreasing in
Australia,19 some parts of the USA,13 and Western Europe,20
with this decrease likely due to earlier detection of the
tumours, possibly as a result of more self-awareness of risks of
skin cancer in subgroups of the population.
Anatomical location. In fair-skinned populations, melano-
mas in older people occur predominantly on the head and
neck and are associated with chronic cumulative exposure to
the sun. In younger people, the lesions most frequently occur
on the trunk and extremities, thought to be the result of high
overall exposure to the sun, episodes of sunburn in childhood,
and the presence of multiple or atypical naevi (moles).21 The
trunk is the site where the greatest increase in the number of
cases in both sexes over the past 30 years has occurred,22,23
likely reflecting the increase in intermittent high dose
exposure leading to sunburn as a result of wearing clothes
with less coverage of the skin, and increased travel to sunny
climates.24
Melanoma in deeply pigmented skin. There is a paucity of
information about the incidence, or any change in incidence,
in CMM in population groups with darker skin. The risk of
CMM is estimated to be around 20-times lower in Black com-
pared to White Americans.25 A recent study in the North-East
USA found no increase in the annual incidence of CMM in
Hispanics and non-Hispanic Blacks since 1992, but a 4%
increase in non-Hispanic Whites.26 In contrast, there is evi-
dence of increasing incidence of CMM in Hispanics from
California between 1988 and 2001.27 Darker-skinned people are
more likely than those with fair skin to have advanced CMM at
diagnosis in the USA26 and in Brazil,28 with a reduced chance
of survival. The lower limb and/or hip is the commonest site
for CMM in the dark-skinned populations of South Africa
(around 70% of CMM) and Kenya (75%),29 particularly the sole
of the foot.29,30 As these body sites are not normally UV-
irradiated, direct exposure to the sun is unlikely to be a risk
factor, although UV-induced systemic eﬀects could be
involved.31
Exposure to the sun as a causative factor in melanoma.
Exposure to the sun is a key risk factor for CMM.32,33 Incidence
is greater at locations closer to the Equator (more UV radi-
ation) in fair-skinned populations.9 For example, in 2012, the
age-standardised incidence (World Standard Population, per
100 000) was 35.8 in New Zealand and 34.9 in Australia, com-
pared to 14.6 in the UK and 9.6 in Canada.7 Epidemiological
studies have shown an increased risk of CMM in people who
self-report higher levels of sunburn, and in those with pheno-
typic characteristics associated with greater sensitivity to UV
radiation, including fair skin, light hair and eye colour, poor
ability to tan, freckling, and having multiple naevi (moles).
Childhood exposure to the sun may be particularly important;
for example, migration from a high to a low latitude location
before age 10 years34 or 20 years35 confers a greater risk of
melanoma than migration at an older age.
Recent experimental studies indicate that both UV-A and
UV-B radiation are involved in the development of CMM.36
Initiation of melanoma following UV-A irradiation involves
oxidative damage to DNA and requires the presence of
melanin, whereas UV-B-induced melanoma is independent of
melanin and involves direct UV-B-induced damage to DNA.36
A two-hit model proposes that initiation of the tumour follows
DNA damage induced by UV radiation, and then progression
to melanoma depends on the host’s genetic make-up
Table 1 Illustrative examples of the change with time in the age-standardised (World Standard Population) incidence of CMM in men and women
(per 100 000 population)
Country Year Incidence Year Incidence Year
Incidence
(projected) Year
Incidence
(projected)
Men
Denmarka 1990 10.0 2007 16.0 2010 16.0 2015 18.0
Englanda 1990 4.6 2006 10.7 2010 12.2 2015 14.5
Spaina 1990 3.1 2004 8.1 2010 8.1 2015 9.3
Netherlandsa 1989 7.4 2007 13.6 2010 15.1 2015 17.5
Australiab 1990 31.1 2000 38.3 2012 40.5 — —
New Zealandc,d 1998–2002 34.8 2012 39.2 — —
Canadac,d 1988–1992 7.7 1998–2002 10.9 2012 10.4 — —
USAc,d 1998–2002 15.1 2012 16.8 — —
Women
Denmarka 1990 12.8 2007 19.5 2010 21.1 2015 24.4
Englanda 1990 6.0 2006 12.3 2010 14.2 2015 16.9
Spaina 1990 3.6 2004 9.5 2010 9.5 2015 10.7
Netherlandsa 1989 10.7 2007 17.3 2010 19.0 2015 21.9
Australiab 1990 25.0 2000 28.8 2012 30.0 — —
New Zealandc,d 1998–2002 31.4 2012 33.1 — —
Canadac,d 1988–1992 6.9 1998–2002 9.3 2012 9.1 — —
USAc,d 1998–2002 11.4 2012 12.6 — —
aData from ref. 10. bData from www.aihw.gov.au. cData from ref. 7. dData from ref. 11.
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(particularly for melanoma of the trunk) and/or tumour pro-
motion by ongoing exposure to both UV-A and UV-B
radiation.37
There is growing interest in the eﬀects of exposures in early
life on the risks of diseases that develop later in life. One indi-
cation that exposure early in life is important for melanoma
comes from observations that, in predominantly fair-skinned
populations, people with the disease are more likely to have
been born in particular months of the year, compared with the
general population. In two studies, young women (aged 15–24
years) with CMM from northern England38 and Sweden39 were
significantly more likely to have been born in March (early
Spring). The data are consistent with the two-hit model
suggested in animal studies37 – early exposure to UV radiation
during the months soon after birth initiates the first event,
then later exposure causes progression to CMM. It is interest-
ing to note that, in the past, exposure of infants to sunlight
was encouraged in some countries, a practice that has not con-
tinued in more recent years.40–43
The higher incidence of small (<2 mm) melanomas during
summer compared to winter in Northern Ireland (1984–2006)
is consistent with exposure to UV radiation having a short-
term promotional eﬀect on melanocytes.44
Genetics of cutaneous melanoma. Susceptibility to CMM is
partially determined by genetic factors (reviewed in Eggermont
et al.5 and Nikolaou & Stratigos12). A family history of CMM
confers a two-fold increase in risk.45 Alternatively, in approxi-
mately 10% of people with CMM, there is a strong family
history,46 associated with specific mutations in genes involved
in control of the cell cycle (e.g., CDKN2A, CDK4). Increased risk
in association with polymorphisms in other genes, including
those associated with fair-skin phenotype (MC1R)46 and
characteristic UV-induced cytosine to thymine (C → T)
mutations in the tumour-control pathways,47 provide strong
evidence of a causal role for UV radiation in the development
of CMM. Very recently, further experimental corroboration for
the involvement of UV radiation in accelerated development of
melanocytes has been obtained.48 Most strikingly, recent
studies show that melanomas (and cell lines thereof) have
more mutations in their genomes than most other tumour
types, e.g., more than 30 000 point mutations per cell, and
hundreds of mutations in protein-coding genes. Tumours
from sun-exposed skin have the greatest number of mutations,
most of which are characteristic of those induced by exposure
to UV radiation.49,50 It is diﬃcult to distinguish causative from
incidental mutations, but special intron–exon comparative
analyses provide evidence of likely causative mutations that are
related to UV radiation.47
Non-melanoma skin cancer
Geographic variation and temporal trends in incidence.
BCC and SCC are the most frequently occurring cancers in
fair-skinned populations. However, establishing accurate inci-
dence data, and comparing incidence rates between countries
or regions, or over time, is challenging for several reasons.
First, these cancers may be treated using destructive therapies
without prior biopsy, and such clinically-diagnosed lesions,
particularly BCC, are often not included in estimates of inci-
dence.51 Diﬀerences in therapeutic approaches between
countries or changes over time can therefore have a consider-
able influence on comparisons and trends. Secondly, there are
very few regions that require mandatory reporting of NMSCs to
cancer registries and population-based studies are rare.
Thirdly, most reports are person-based rather than lesion-
based so they do not account for the multiple lesions often
observed in people living at lower latitudes; and lastly, variabi-
lity in the population used to age-standardise incidence rates
makes reported results diﬃcult to compare.
Despite these diﬃculties, there is a strong association
between intensity of ambient UV radiation and incidence of
both BCC and SCC.52 In a recent review, the highest annual
incidence rates were in Australia (>1000 per 100 000 population
for BCC) and the lowest in Africa (<1 per 100 000 population).53
Data for the latter are sparse and the low incidence masks rela-
tively high incidence in some sub-populations, for example
among people with oculocutaneous albinism (OCA) [see
section below], and in Caucasians in South Africa, where BCC
and SCC are typically among the top 5 or 10 cancers reported
(depending on year).54
There have been substantial increases in the incidence of
NMSC over the past several decades. Across Europe, the
annual incidence of BCC was estimated to be around 50 per
100 000 persons in 1980.53 It has more than doubled since
then in many parts of this region, and has quadrupled in the
Netherlands.55 The incidence of SCC was approximately 10 per
100 000 persons in Europe in 198053 with an increase to
about 25 per 100 000 by 2000.53 There are no estimates of SCC
and BCC separately for the United States, but a study of a
study of data from national Medicare claims suggests that the
age-adjusted rate of procedures for skin cancer increased by
77% between 1992 and 2006.56
A recent quantitative review of data published between 1979
and 2012 showed that, in fair-skinned populations worldwide,
after adjustment for age, sex, and the levels of ambient UV
radiation, the average annual increases in SCC and BCC inci-
dence were 4% and 1%, respectively.52 The incidence of SCC
increased over time in both the older (≥60 years) and younger
(<60 years) age groups, but only in the older age group for
BCC.
Exposure to the sun as a risk factor for non-melanoma skin
cancer. As the studies showing latitudinal variation suggest,
exposure to solar UV radiation is the primary cause of BCC
and SCC; almost 40% of the variability in incidence in SCC
and BCC in populations of predominantly European ancestry
could be explained by diﬀerences in the average daily levels of
ambient UV radiation alone.52 Nevertheless, evidence suggests
that the timing and patterns of exposure to the sun that give
rise to the two tumour types are diﬀerent. SCC appears to be
strongly associated with cumulative exposure to the sun. In
fair-skinned people, SCC is rare on parts of the body that are
not routinely exposed to the sun57–59 and the presence of
actinic keratoses, which are a marker of cumulative exposure
Perspective Photochemical & Photobiological Sciences
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to the sun, confers a 30–40-fold increase in the risk of SCC.60
In contrast, BCC appears to be caused by intermittent exposure
to the sun;61,62 up to 25% of BCCs occur on the trunk or lower
limbs59 and the association with actinic keratosis is consider-
ably weaker than for SCC.63 However, some studies have found
no diﬀerence in the pattern of exposure in relation to the risk
of BCC and SCC,64 possibly because the risk factors for BCC
vary according to the site and/or subtype of BCC. For example,
chronic exposure to the sun may be more important for
nodular BCC commonly found on the head and neck, and
intermittent exposure to the sun more important for super-
ficial BCCs that have a tendency to occur on the trunk.65 It is
of interest to note that there is a 3-fold increased risk of devel-
oping CMM after either SCC or BCC, even after adjustment for
the self-reported reaction of the skin to chronic exposure to
the sun.66 This may indicate risk factors in common between
the NMSCs and CMM, e.g., susceptibility of specific skin
phototypes, and excessive (intermittent) exposure to the sun.
Non-melanoma skin cancer in more deeply pigmented skin.
There have been few studies of incidence of NMSCs in dark-
skinned populations.53 Data collected by the National Cancer
Registry of South Africa in the early 2000s indicated that the
annual age-standardised incidence (per 100 000) of reported
SCC was 4.6, 7.0, 41.5 and 101.3, and of reported BCC was 4.7,
13.0, 85.7 and 311.1 in the Black, Asian, Coloured and White
population groups respectively.30
The epidemiology, clinical presentation, and prognosis of
NMSC diﬀer between people with fair skin and those with
darker skin. For example, in several studies, SCC was more
common than BCC in those with deeply pigmented skin29,67
and these tumours typically arose in sites of chronic inflam-
mation or scarring, so that solar UV radiation may not be the
major risk factor.31 In contrast, the site-distribution of BCCs is
similar in fair- and dark-skinned populations, occurring pre-
dominantly on the head or neck, suggesting that exposure to
UV radiation is an important risk factor.
Over time, there has been little increase in the incidence of
NMSC in Asian populations and almost none in dark-skinned
populations (reviewed in Agbai et al.31 and Gloster & Neal,68).
However, mortality and morbidity from NMSC is disproportio-
nately high in dark-skinned populations in comparison with
incidence, due to diagnosis occurring at a more advanced
stage, atypical presentation, lack of screening, and socio-
economic factors.31 Public health education regarding protec-
tion against the sun and self-awareness, tailored appropriately
for each population group, should be expanded to include
people of all skin types.69
Genetics of non-melanoma skin cancer. Common variants
in several genes influence the risk of BCC, including those in
known pigmentation genes.70,71 In addition, there are rare
genetic disorders in which NMSCs arise at a young age and
incidence is dramatically increased. For example, incidence of
skin cancer in people under the age of 20 years is increased
10 000-fold in patients with xeroderma pigmentosum, a dis-
order where the repair of UV-induced DNA damage is severely
impaired.72
SCCs and BCCs are the cancers with the highest mutational
loads (33 and 76 mutations per million DNA-bases, respect-
ively), especially those from skin regularly exposed to the
sun.73,74 The majority of these mutations bear the “UV signa-
ture” (cytosine to tyrosine transitions at cyclobutane pyrimi-
dine dimers, CPD, Fig. 1). Both BCC and SCC show UV-
signature mutations in tumour suppressor genes (PTCH1 and
p53 respectively),74–76 suggesting these are key abnormalities
driving the development of these tumours.77 These genetic
studies clearly indicate the causal role of exposure to UV radi-
ation in the development of NMSC.
Skin cancer in oculocutaneous albinism. Oculocutaneous
albinism (OCA) refers to a group of congenital developmental
disorders in which there is either partial or complete lack of
melanin in the skin, hair and eyes.78 The number of melano-
cytes is not reduced, but there is decreased or absent pro-
duction of melanin due to mutations in genes in the melanin
biosynthetic pathway.78 The four major types (OCA1, 2, 3 and
4) are present at diﬀerent frequencies in various populations
throughout the world; for example OCA2 is the most common
type in sub-Saharan Africa.78 Globally, about 1 in every 17 000
people have OCA (with about 1 in 70 people carrying the OCA
gene),79,80 but this figure can be considerably higher, such as
1 in 3900 in South Africa.81
People with OCA experience visual impairment including
photophobia (discomfort from exposure to light, leading to
avoidance).82 They are also highly susceptible to skin damage
induced by solar UV radiation and it has been estimated that
the risk of NMSC in people with OCA in Africa is one thousand
times greater than that of the general population.83 In most
instances, the skin cancer occurs at 20–30 years of age, which
is considerably younger than in those without OCA.84
Cutaneous tumours in Africans with OCA are predominantly
Fig. 1 Human skin shows cyclobutane pyrimidine dimers (CPD, red
nuclei) when a biopsy is taken immediately after 4 standard erythema
doses of simulated solar radiation. Note the presence of CPD in the epi-
dermal basal layer that contains stem cells and that CPD are also
present in the dermis. Photograph provided by Professor Antony Young,
Faculty of Life Sciences and Medicine, Kings College London, UK.
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SCCs, with BCCs less frequent, and CMMs only occasionally
seen,85,86 although the last may be under-reported as they are
normally amelanotic (non-pigmented).87 Most commonly, the
skin cancers in Africans with OCA occur on the head and neck
and tend to progress rapidly with metastasis to the cartilage,
bone, and muscle, resulting in high mortality.84,88 The key role
of exposure to the sun in the oncogenic process is emphasised
by finding an increased frequency of skin tumours and lower
life expectancy in people with OCA living in equatorial regions
of sub-Saharan Africa than in parts further from the Equator.84
Viruses and skin cancer
There are two instances (see following sections) where an
association between certain viruses and skin cancer has been
demonstrated. In both cases, the tumours occur predomi-
nantly on body sites most exposed to the sun, suggesting that
exposure to solar UV radiation is likely to play a crucial role in
the carcinogenic process.
Merkel cell carcinoma and polyomavirus. Merkel cell carci-
noma (MCC) is a rare, aggressive, neuroendocrine skin cancer
with high rates of recurrence, metastasis, and mortality.89 It
mainly aﬀects fair-skinned, elderly people (peak age around 75
years) or those who are immunosuppressed, particularly if they
live in a sunny location.89 The tumours occur most frequently
on sun-damaged skin on the head and neck.90 There is a posi-
tive correlation between ambient levels of UV radiation and
age-adjusted incidence of MCC across the USA.91 The inci-
dence has risen in recent years, for example, from 0.15 cases to
0.44 cases per 100 000 between 1986 and 2001 in the USA.92
This could be explained by increasing life expectancy, greater
exposure to the sun and the rising number of immunosup-
pressed people in the general population as a result of an
increasing number and range of organ transplants93 and infec-
tion with HIV.89
Merkel cell polyomavirus is present in around 80% of
MCCs. The viral DNA is integrated into the host DNA and is
thought to cause cancer after genomic mutations that elimi-
nate its ability to replicate but maintain its oncogenic function
(reviewed in Arora et al.94). Exposure to UV radiation may play
a role in the integration or mutagenic processes (for example,
Demetriou et al.95 and Mogha et al.95,96) or in suppression of
the immune response to the virus.97
Squamous cell carcinoma and papillomaviruses. Human
papilloma viruses (HPVs) can infect the squamous epithelium
of the skin and may play a causative role in the development of
cutaneous SCC. There are many types of HPVs; phylogenetic
analysis describes 120 diﬀerent types across 5 genera.98 Several
studies have found that the presence in serum of antibodies to
the beta or gamma HPV types is associated with an increased
risk of SCC.99–101 Furthermore, people with SCC have higher
levels of beta HPV DNA in hair follicles of the eyebrow (used as
a marker of infection) than controls without SCC.102 The beta
and gamma HPV types code for proteins that aﬀect the normal
controls of the cell cycle and may also subvert the normal
immune response. The mechanism by which various types of
HPV might influence the risk of cutaneous SCC is unclear, but
is most likely through potentiating the eﬀects of exposure to
UV radiation.103
Photoageing
Chronic exposure to solar UV radiation results in photoaged
skin, which is wrinkled, leathery, shows loss of elasticity, and
is often associated with the development of SCC. Photoageing
results from the UV-induced degradation of proteins such as
collagen and elastin in the extracellular matrix of the dermis.
UV-A radiation may be primarily responsible for chronic photo-
ageing, given its greater depth of penetration.104 In addition, a
role for UV-B radiation is indicated. First, UV-B radiation can
directly degrade some proteins, such as fibrillin and fibronec-
tin, involved in maintaining the structure of the dermis.105
Second, the action spectrum for the induction of matrix metal-
loproteinase (an enzyme that degrades collagen) in human
skin is similar to that for erythema (reddening of the skin,
inflammation), suggesting that this is primarily an eﬀect of
exposure to UV-B radiation.106 While not a risk to health
per se, photoageing of the skin incurs considerable costs
through the use of cosmetic and hydrating agents to improve
the appearance and feel of the skin.
Melasma
Melasma appears as dark, macular, pigmented patches on the
brow, cheek, upper lip and jaw, and is due to a localised
increase in melanin production.107 It can result in profound
emotional and psychological stress, significantly reducing
quality of life.108 Melasma is particularly common in adult
women living in tropical areas of the world and occurs more
frequently in individuals with skin types of intermediate pig-
mentation (i.e., types III–V) than in those with fair (skin types I
and II) or very dark skin (skin type VI).107,109 Its prevalence has
been estimated as 3.4% in the general population in Beirut,
Lebanon, 10.1% in Cuzco, Peru,107 34% in adult women in
Botucatu, Brazil,110 and 40% in adult women and 20% in
adult men in South-East Asia.111
The precise pathophysiology of melasma is unclear, but is
known to be complex. There is a genetic predisposition and
several environmental triggers, one of which is exposure to
sunlight. For example, a report from Tunisia indicated that
51% of patients recognised exposure to the sun as a triggering
factor and 84% as an aggravating factor, with high lifetime
exposure to the sun increasing the risk of severe melasma
three-fold.112 A case-control study in Brazil found that patients
with melasma had a greater number of years of seaside or
rural residence and greater exposure to the sun at work or
during leisure than the controls; there was a lack of association
with sunburn, implying that cumulative exposure to the sun
may be more important than acute exposure.109 Solar UV radi-
ation can induce proliferation and migration of melanocytes113
and the production of several cytokines that increase the pro-
duction of melanin. In addition, inflammatory cells, especially
mast cells, which produce a variety of potent pro-inflammatory
substances, are likely to play key roles.114
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Eﬀects of solar UV radiation on the eye
The eye is partly protected from direct UV radiation by the
brow ridges. This means that reflected radiation is likely to
contribute more to the total UV radiation received than occurs
for the skin. Higher intensity UV radiation induces the most
damage, although less intense exposure over a long period
also increases the risk of disease. Transmission of UV radi-
ation through the eye (Fig. 2) generally decreases with increas-
ing age, but there is wide inter-individual variability.115 The
cornea filters out wavelengths less than about 280 nm,
although this is relevant for artificial sources only, as sunlight
at the Earth’s surface is confined to wavelengths >290 nm.
There is further absorption in the aqueous humour (Fig. 2).
The lens of a young child (e.g., <5 years) transmits close to
100% of the visible light spectrum (wavelength >400 nm), but
absorbs UV radiation, except for a small window at 320 nm.116
The lens of an older person (e.g., 60+ years) commonly filters
out even some of the short blue visible light (400–500 nm) so
that this, and UV radiation of shorter wavelengths, do not
reach the retina.
Exposure to UV radiation increases the risk of a number of
ocular conditions, with the strongest evidence of a specific
eﬀect of UV-B radiation for photokeratitis, pterygium, and
cataract.
Photokeratitis and photoconjunctivitis
Exposure of the eye to high-dose UV radiation from the sun
can result in inflammation of the cornea (photokeratitis) and/
or conjunctiva (photoconjunctivitis) (Fig. 2). The maximum
sensitivity is to the UV-B wavelengths.117 The damage is prob-
ably caused by oxidative stress,118–120 with the squamous cells
of the epithelium of the cornea, the keratocytes of the stromal
layer of the cornea, and the endothelial cells lining the back of
the cornea, being aﬀected.
Transmission of UV radiation decreases across the cornea
from the centre to the periphery, due to scattering and absorp-
tion.121 The centrally located endothelial cells receive a higher
dose of UV radiation, and show evidence of higher oxidative
stress than cells in the periphery. It is the damage to these
central corneal endothelial cells that particularly causes
corneal swelling and temporary loss of vision in UV-induced
photokeratitis.121
Pterygium
Pterygium, a wing-shaped invasive growth of the conjunctiva
(Fig. 3), is common in adults living in environments with high
UV radiation. For example, it aﬀects at least one eye in approxi-
mately 10% of: adults (≥15 years) on Norfolk Island,
Australia;122 south Indians (≥40 years) in Chennai, India;123
and indigenous people (≥40 years) in Central Australia.124
Some recent studies show that the prevalence of pterygium
increases with increasing age and is more common in men
than women,123 but the increase with age is not consistently
found.125 Key risk factors for pterygium are greater time out-
doors (including sports with high ocular exposure to UV radi-
ation, such as surfing126), rural residence, having a skin type
that tans122 and non-use of spectacles.123 Of note, the only
study that has examined the risk of pterygium in association
with wavelengths of solar radiation other than those in the UV
range (using retrospectively reconstructed exposure behaviour
during working hours) found a stronger association with
visible light, and a weaker but still significant association with
UV-B radiation.127 Recent evidence suggests that a pterygium
Fig. 2 A schematic drawing of a section through the human eye, with an enlarged schematic of the lens to the right.
Fig. 3 Pterygium of the eye; photograph provided by Dr David Mackey,
University of Western Australia, Perth, Australia.
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is not always benign: there is histological evidence of inflam-
matory and dysplastic changes in the epithelium and under-
lying connective tissue,128 and of neoplasia in 2–10% of
excised pterygia.129,130
Squamous cell carcinoma of the cornea and conjunctiva
Squamous cell carcinoma of the cornea and conjunctiva
(SCCC) is rare; the annual incidence in the USA is estimated to
be 0.84 per 100 000 population.131 The incidence is higher in
men, and in association with older age, residence at lower lati-
tude, infection with HIV, and high exposure to UV radiation.131
Infection with HPV and exposure to UV radiation may be
common risk factors for pterygium and SCCC.132
Cataract
In 2010, cataract was the leading cause of blindness world-
wide.133 Of the three main types of age-related cataract – corti-
cal, nuclear, and posterior subcapsular (Fig. 2) – UV radiation
is primarily linked to an increased risk of cortical cataract.134
The action spectrum for acute/short term cataract develop-
ment is relatively consistent across animal models, with UV-B
radiation of shorter wavelengths being most damaging.135
However, these models have limited relevance for cataract
formation in humans because of wide inter-species variation
in the dose of UV irradiation required,136 and the typical use
of a single very high dose, rather than repeated lower doses.
Melanin in pigmented irises may absorb UV radiation, leading
to fewer cataracts in those with more pigmented, than
less pigmented, irises.137 Lenses in older individuals may be
more susceptible to UV-induced cataracts due to poorer
defence against oxidative damage and decreased repair
mechanisms.138–140
In the large Salisbury Eye Evaluation Study with partici-
pants aged 65–84 years, the incidence and progression of corti-
cal cataract (but not nuclear cataract) were associated with
higher levels of estimated exposure to UV-B radiation (calcu-
lated based on an empirical model incorporating self-reported
time outdoors and use of protection from the sun).141 In con-
trast, in the 15 year follow-up of participants in the Beaver
Dam Eye Study,142 there was no association between exposure
to the sun (as measured by residential history) and cumulative
incidence of any type of age-related cataract, after controlling
for age and sex. However, the combined use of sun-sensitising
medications and high exposure to the sun led to a significantly
increased risk of cortical cataract.142
Ocular malignancies
There is strong evidence to support exposure to UV radiation
as a risk factor for tumours of the eyelid and weaker evidence
for ocular melanomas (reviewed in Yam and Kwok143). Over
90% of the malignancies of the eyelid are BCCs, particularly
aﬀecting the lower lid (50–65%), but also the medial canthus
(inner corner of the eye, 25–30%), upper eyelid (15%) and
lateral canthus (outer corner of the eye, 5%).143 SCC accounts
for most of the remainder of the periocular cutaneous
tumours.143
Melanomas of the eye can involve the surface (i.e., the
eyelid or conjunctiva), or occur at an intra-ocular location,
aﬀecting the elements of the uvea (i.e., the iris, ciliary body,
and choroid; Fig. 2). Uveal melanoma is the most common
primary intraocular malignancy (>90%) and the leading cause
of death from intraocular cancer.144,145 The reported annual
incidence varies from 0.53 to 1.09 cases per 100 000 popu-
lation, and is stable or decreasing.144,145 Uveal melanoma is
primarily a disease of white populations; light-coloured irises,
blond hair, and fair skin are risk factors.146 There is mixed evi-
dence implicating UV radiation as a risk factor for uveal mela-
noma: latitudinal variation in incidence is not consistently
found;145 occupational exposure to UV radiation may have a
protective eﬀect, but intermittent exposure may increase risk
(reviewed in Mallet et al.146). People with the disease xero-
derma pigmentosum, in which there is impaired ability to
repair UV-induced DNA damage (see discussion above), have a
58-fold increased risk of uveal melanoma.146,147 Genetic
studies show that the mutation patterns of the most frequently
mutated genes in CMM and uveal melanoma (i.e., BRAF vs.
GNAQ, GNA11) are similar,146 and a mutation recently identi-
fied in CMM (RAC1) is also found in 20% of uveal melanoma
cell lines.146 Given the strong evidence supporting a role for
UV radiation as a cause of CMM, these studies also provide
some evidence that exposure to UV radiation is a risk factor for
uveal melanoma.
Age-related macular degeneration
Age-related macular degeneration (AMD) was the cause of 7%
of blindness worldwide in 2010,133 and was the most frequent
cause of blindness in older (50–75 years) white populations in
Europe.148 UV radiation had been discounted previously as a
risk factor in AMD as it does not reach the retina. However,
recognition of the considerable individual variability in the
transmission of longer UV-B/shorter UV-A wavelengths
(<320 nm) in older adults (60+ years) has led to reconsidera-
tion of a potential role of UV radiation. Possible mechanisms
include: UV-induced oxidative damage to mitochondrial DNA,
particularly in the macular region of the neural retina and the
retinal pigment epithelium;149 and/or upregulation of inflam-
matory cytokines (e.g., IL-6) and transcription factors (e.g.,
STAT3). Higher vitamin D status is associated with lower risk
of AMD in women <75 years, but a higher risk in women
≥75.150
In a systematic review and meta-analysis of case-control and
cross-sectional studies, higher exposure to the sun was associ-
ated with a 38% increase in the odds of having AMD.151
However, blue light (400–500 nm) may be more important
than UV radiation as a risk factor for AMD.143,152,153
Other possible eﬀects on the eye
There is a well-established association between spending less
time outdoors and an increased risk of developing myopia in
childhood.154–157 While early hypotheses focused on the
importance of variation in focal length with a mix of indoor and
outdoor activities, more recent work suggests the importance
Perspective Photochemical & Photobiological Sciences
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of exposure to light, possibly through increased secretion of
dopamine in the retina, with eﬀects on the growth of the
eye.158 The wavelength dependence of this eﬀect, and whether
the pathways are mediated by vitamin D159 or not,157 are cur-
rently unknown.
Evidence from animal studies suggests that UV irradiation
of the eye can cause systemic immunosuppression,160,161 but
the relevance of these findings for human health is unclear at
present.
Eﬀects of solar UV radiation on
immune function and consequences
for disease
Mechanisms
UV photons penetrate the epidermis and upper dermis162 and
are absorbed by chromophores (Table 2), which then initiate a
cascade leading to changes in immune responses.
While much of this information has been gathered from
studies in vitro or in rodent models, less is known about
humans. However, an action spectrum for the UV-induced sup-
pression of the human immune response to a previously-
encountered antigen (termed memory or recall immune
responses) has been constructed: it has two peaks, one within
the UV-B waveband at 300 nm and one at 370 nm in the UV-A
waveband.164,165 There is also evidence from studies in both
humans and mice that interactive and additive eﬀects between
wavebands can occur.166–168
Briefly, exposure to UV radiation causes up-regulation of
some innate immune responses, and down-regulation of some
acquired primary and memory immune responses, mainly
through eﬀects on T cell activity (reviewed in Gibbs &
Norval,163 Schwarz & Schwarz,169 and Ullrich & Byrne170). The
up-regulation includes the production of several antimi-
crobial peptides (AMPs) in the epidermis,171,172 possibly
through a vitamin D pathway (see below). The AMPs provide
immediate protection against a variety of pathogens (bacteria,
fungi, and viruses having a viral envelope) and they are also
involved in the promotion of cell growth, healing, and angio-
genesis. In contrast to these stimulatory functions, exposure to
UV radiation induces T regulatory cells (Tregs) and other cell
types which contribute to immunosuppression and help to
restore cutaneous homeostasis.172,173 Mediators such as plate-
let-activating factor, prostaglandin E2, histamine, and tumour
necrosis factor-α are produced locally at the irradiated site.
These alter the migration patterns and functions of various
populations of immune cells. The end result is the generation
of cell subsets with suppressive activity which are thought to
remain for the life-time of the individual.174,175
The UV-induced alterations in the normal immune
response can be beneficial for some human diseases and detri-
mental for others. Vitamin D, synthesised following exposure
of the skin to UV-B radiation, also has positive and negative
eﬀects on immune-related diseases. Indeed, it is diﬃcult to
distinguish between immunoregulation by vitamin D and
other mediators induced by UV radiation,176–180 since the
downstream eﬀects on immune parameters are similar. For
clarity, the eﬀects of UV radiation and those of vitamin D have
been assessed separately in the sections below. We first focus
on the eﬀects of UV radiation on immunity, and address
vitamin D-related eﬀects on immune function in the section
specifically on vitamin D.
Polymorphic light eruption
Polymorphic light eruption (PLE) is the commonest of the
photodermatoses, with a prevalence of up to 20%.181 PLE
manifests as an intermittent itchy red skin eruption which
resolves without scarring after a few days to weeks. It occurs
2–3 times more frequently in women than in men, with onset
typically in the first three decades of life,181 and is found pre-
dominantly in those with fair skin, although all skin types can
be aﬀected.181 A recent study of Indian patients with dark skin
phototypes (IV and V) who suﬀered from various photoderma-
toses revealed that PLE was the commonest of these, aﬀecting
60% of the group.182 The lesions occur most often in the
spring and early summer or during a sunny holiday, following
the first exposure to a large dose of sunlight. After repeated
exposures, the lesions are less likely to occur. This process,
called photohardening, is used therapeutically with good
results. Recent investigations indicate that key events in photo-
Table 2 Cutaneous chromophores involved in the initiation of UV-induced changes in immune function (reviewed in ref. 163)
Chromophore Change in structure following irradiation Eﬀect on immune function
DNA Cyclobutane pyrimidine dimers and reactive oxygen
species-induced base oxidation after exposure to
radiation in both the UV-A and UV-B wavelengths
Oxidative stress; up-regulation of several
immunosuppressive mediators and down-regulation of
some immunostimulatory mediators
trans-Urocanic acid cis-Urocanic acid (peak eﬀectiveness of isomerisation
about 300 nm)
Oxidative damage; up-regulation of several
immunosuppressive mediators; stimulation of
neuropeptides; mast cell degranulation; cell growth arrest
Membrane
phospholipids
Oxidative stress and lipid peroxidation Clustering of receptors; activation of transcription factors;
release of immune mediators
7-Dehydrocholesterol Previtamin D after UV-B irradiation, leading to vitamin D,
then 25-hydroxyvitamin D and finally the active form,
1,25-dihydroxyvitamin D
Up-regulation of some antimicrobial responses and DNA
repair; down-regulation of most acquired immune responses
Tryptophan Activation of the arylhydrocarbon receptor following
exposure to UV-B radiation
Clustering and internalisation of growth factor receptors
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hardening include a decrease in the number of Langerhans
cells in the epidermis and recruitment of mast cells into the
dermis,183 together with changes in systemic cytokine levels.184
PLE is immunologically-mediated as a result of a failure to
establish the normal suppression of immune responses follow-
ing exposure to UV radiation. The antigen involved has not
been identified but is likely to be novel, induced by the DNA
damaging properties of UV radiation. Various abnormalities in
the cutaneous immune response following UV radiation have
been demonstrated in people with PLE compared with con-
trols.185,186 This disease therefore illustrates the positive evo-
lutionary advantage of UV-induced immunosuppression in
individuals who are not susceptible to PLE and what can
happen if it is absent.
Asthma
Asthma comprises a group of diseases that evidence as wheeze,
chest tightness, or shortness of breath, occurring as a result of
obstruction of the airways and restriction of airflow that is
usually reversible. The level of severity, frequency of symptoms,
age of onset, main inflammatory phenotypes, and triggers and
pathways are variable. This heterogeneity may explain the
current lack of consistency in results from studies examining
the relationship between UV radiation and the risk of asthma.
There are anecdotal accounts that sunny holidays or living
at high altitude decrease asthma symptoms. The prevalence of
asthma was inversely associated with the intensity of UV radi-
ation,187 or past personal exposure to solar UV radiation.188
However, in a study where diﬀerent sub-types of asthma were
considered, residence at latitudes closer to the equator (and
with greater intensity of UV-B radiation) was associated with
an increased risk of having asthma in atopic participants (with
a history of allergic responses to specific antigens) but a
decreased risk in those without atopy.189 These findings high-
light the importance of diﬀerentiating between subtypes of
asthma in examining associations with exposure to UV radi-
ation. Nevertheless, individual-level exposure to UV radiation
was not measured (only latitude and ambient UV radiation), so
the results could reflect exposure to other latitude-associated
factors such as temperature and indoor heating.
Infection and vaccination
Studies over the past 20 years have shown that exposure to
solar UV radiation suppresses microbe-specific acquired
immune responses in animal models of infection. This modu-
lation can lead to an increased microbial load, reactivation
from latency, and more severe symptoms, including death
(reviewed in Norval et al.190). A recent study showed that
spending 8 or more hours outdoors per week when the UV
Index was ≥4 was associated with an increased risk of ocular
recurrence of herpes simplex virus (HSV) infection resulting in
eruptive lesions.191 UV radiation prior to vaccination causes a
less eﬀective immune response in several mouse models
(reviewed in Norval & Woods192), but whether exposure to UV
radiation adversely aﬀects the course of infections and the
eﬃcacy of vaccination in humans remains an open question.
Despite the paucity of new information, there remains the
possibility that UV-induced immunosuppression could convert
an asymptomatic infection into a symptomatic one, reactivate
a range of persistent infections, increase the oncogenic poten-
tial of microbes, and reduce the memory immune response,
for example after vaccination, so that it is no longer protective.
Autoimmune diseases
Many autoimmune diseases are considered to have both
environmental and genetic risk factors. Evidence to support
the importance of environmental exposures comes from geo-
graphical variation (changing incidence with changing lati-
tude), temporal patterns (such as variations in incidence with
season or season-of-birth) and results from observational epi-
demiological studies. Several studies show an inverse associ-
ation between exposure to UV radiation and immune-mediated
diseases, suggesting that the UV may be protective. In many
cases, the assumed pathway has been through enhanced syn-
thesis of vitamin D (see section on Vitamin D below). However,
this evidence is now being re-evaluated in light of possible
alternative pathways, including UV-induced immune modu-
lation and altered susceptibility to relevant viral infections,
and non-UV pathways such as changes in the secretion of
melatonin (reviewed in Hart et al.193). While there have been
suggestions that exposure to UV radiation may be important
for conditions such as inflammatory bowel disease (for
example, Nerich et al.194), type 1 diabetes,195 and rheumatic
diseases (including rheumatoid arthritis, systemic lupus
erythematosus, dermatomyositis, and others),196 the strongest
evidence is for multiple sclerosis.
Multiple sclerosis. Many studies (but not all) have shown
that the prevalence, incidence, or mortality from multiple
sclerosis (MS) increases with increasing latitude and decreas-
ing altitude or intensity of ambient UV radiation, in predomi-
nantly fair-skinned populations (reviewed in Hewer et al.197).
In the US Nurses Health Studies, a latitudinal gradient present
in a cohort of female nurses born before 1946 was not appar-
ent in a similar cohort born after 1946.198 The findings
reflected an increase in incidence in the south in the later
cohort (rather than a decrease in the north). One explanation
given to explain this change was that increasing sun-protective
behaviours in the south had reduced the diﬀerence in per-
sonal dose of UV between the north and south.199 Studies
from the northern200 and southern201 hemispheres show that,
compared to the general population, people with MS were
more likely to have been born in late spring and less likely to
have been born in late autumn. This timing would be consist-
ent with a hypothesis that exposure of the mother to more UV
radiation during the late first trimester, when the foetal
nervous system is developing and maturing, is protective for
the development of MS in later life.201 Alternatively, it is also
possible that exposures early in infancy, rather than in preg-
nancy, influence risk, or other factors that vary seasonally
could be important. Animal studies suggest that UV-B
irradiation can prevent the onset of experimental autoimmune
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encephalomyelitis, used as a model for MS,202 and there is
supportive evidence from recent studies in humans.203,204
The role of UV-induced immune suppression in skin cancer
Cutaneous malignant melanoma. Evidence that the
immune response is important for the development of CMM
is clearly shown by the increase in incidence following organ
transplantation that requires ongoing treatment with immuno-
suppressive medications.205 UV radiation, particularly UV-B,
can cause suppression of many aspects of cell-mediated immu-
nity but, until recently, how it influenced the initiation of
CMM was unknown. In a transgenic mouse model, the recruit-
ment of macrophages to the skin following UV-B irradiation
and their subsequent proliferation were shown to be critical in
the survival of melanocytes, including those with UV-induced
DNA damage.206–208 In addition, inflammation induced by UV
radiation increased metastasis of melanoma, with neutrophils
being the main drivers of the inflammatory process.209 Con-
sistent with these reports from animal models, in patients
with metastatic melanoma there was a shorter survival time if
metastases contained a high proportion of macrophages.210
Non-melanoma skin cancer. Tumours induced by UV radi-
ation are highly antigenic. UV-induced immune suppression
plays a critical role in the development of NMSC as evidenced
by the dramatically increased incidence in immunosuppressed
people, for example, following organ transplantation.211 This
is especially shown for SCCs in organ transplant recipients
receiving immunosuppressive drugs that suppress T cell
activity, suggesting that eﬀector T cells are of particular impor-
tance in the control of SCC.212 Furthermore, Tregs induced by
UV irradiation infiltrate SCCs and surround BCCs. Pharmaco-
logically blocking steps in the pathway of UV-induced immu-
nosuppression may be eﬀective in preventing the development
of skin cancers and actinic keratoses.212–214
UV-induced vitamin D and its eﬀect
on health
Metabolism of vitamin D
Vitamin D can be synthesised in the skin or ingested in the
diet or as a supplement. The pathway by which vitamin D is
produced in the skin and metabolised to its active form, 1,25-
dihydroxyvitamin D (1,25(OH)2D) is shown in Fig. 4. Synthesis
is initiated by absorption of UV-B radiation by 7-dehydrocho-
lesterol. The enzymatic steps converting vitamin D to 1,25
(OH)2D occur predominantly in the liver and the kidney but
also in other tissues, including the skin.
Both pre-vitamin D3 and vitamin D3 can be converted to
inactive photoproducts by continued UV-A or UV-B irradiation
(discussed in Galkin & Terenetskaya215 and Norval et al.216).
Once pre-vitamin D has formed and isomerization to vitamin
D has occurred, there is preferential degradation of vitamin D
compared with synthesis of pre-vitamin D at wavelengths of
UV radiation between 300–330 nm.217 This may explain why
vitamin D toxicity from exposure to solar UV radiation does
not occur and may be of importance to public health messages
about safe exposure to the sun – recurrent shorter periods of
Fig. 4 Synthesis of vitamin D and the vitamin D metabolic pathway. VDBP: vitamin D binding protein; 25(OH)D: 25-hydroxyvitamin D; 1,25(OH)2D:
1,25-dihydroxyvitamin D; T1/2: half-life.
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exposure to the sun are preferable to prolonged exposure to
achieve vitamin D production while minimizing UV-induced
damage of DNA.218
Vitamin D status – assessment and geographic variability
Vitamin D status is assessed by measuring the concentration
of the intermediate metabolite, 25-hydroxyvitamin D
(25(OH)D) (Fig. 4) in serum. Vitamin D deficiency is reportedly
widespread globally, but it is important to note that there are
considerable problems with the accuracy and reproducibility
of vitamin D assays219 as well as a lack of consensus on the
concentration of 25(OH)D that denotes deficient, insuﬃcient,
suﬃcient, or optimal vitamin D status.220 Common cut-oﬀ
points are provided in Table 3.
There is a striking lack of data on the vitamin D status of
infants, children, and adolescents and an almost complete
lack of data from Africa and South America.225–227
Variation in vitamin D status according to latitude is appar-
ent when results arise from a single assay with good agree-
ment across batches of samples,228 and is stronger where
blood is taken in winter compared to summer.229 Comparisons
across studies may not show a latitudinal gradient due to the
analytical challenges and lack of standardisation of the season
of blood collection.225–227 In addition, contributions to
vitamin D status from dietary intake and sunny holidays may
obscure latitudinal gradients that would otherwise occur. For
example, a lower latitude holiday in the previous year with the
purpose of sun-bathing was associated with higher 25(OH)D
levels by 20–30 nmol L−1 in the following winter months in
residents of Uppsala, Sweden.230
Skin pigmentation and vitamin D status
Within a given location, people with darker skin commonly
have lower concentrations of 25(OH)D than those with fairer
skin231,232 and this is usually attributed to the photoprotective
properties of melanin. However, recent work highlights the
importance of cultural practices, or personal preferences,
leading to avoidance of the sun.233 In a recent study, however,
black Americans (n = 2085) had lower concentrations of 25
(OH)D, but also lower concentrations of vitamin D binding
protein, than white Americans.231 The consequence of this was
similar (calculated) levels of “free” (not bound to vitamin D
binding protein) or loosely bound (to albumin), i.e., bioavail-
able, 25(OH)D. This observation may explain why black people
with low total 25(OH)D have higher bone mineral density than
white people with similar 25(OH)D concentrations. Further-
more, it may mean that vitamin D status should be defined
by the concentration of bioavailable, rather than total,
25(OH)D.234,235
Several recent experimental studies have examined the
impact of pigmentation of the skin on synthesis of vitamin
D. Most of these,236,237 although not all,238 show that for a
specific dose of simulated solar UV irradiation there is a
greater increase in the concentration of 25(OH)D in fairer-
skinned than in darker-skinned participants. The lack of eﬀect
in the latter study has been attributed to the short wavelength
UV-B output from the source lamp, resulting in penetration
only into the superficial layers of the epidermis above the
main concentration of melanin.239
Exposure to the sun and vitamin D status
In general, laboratory studies show an initial linear dose–
response between exposure to UV radiation and change in con-
centration of 25(OH)D,240 but a plateau with continuing
exposures over a longer period of time.218,241–243 Results
suggest that the shape of the dose–response curve depends on
the baseline concentration of 25(OH)D, with a greater response
to UV irradiation238 and no plateau eﬀect in those with a lower
starting concentration (<50 nmol L−1),244 although conflicting
results have also been obtained.245
Understanding the relationship between the dose of UV
radiation, the surface area of skin exposed and the production
of vitamin D is important for the development of public health
messages. Results from population-based epidemiological
studies and experimental studies using artificial irradiation
demonstrate that exposing a larger area of skin to UV
radiation results in a greater increase in the concentration of
25(OH)D.246,247 Field studies have shown that increases in the
concentrations of 25(OH)D are positively associated with DNA
damage (assessed by concentration of CPDs in urine),
suggesting that improved vitamin D status is always associated
with some potentially mutagenic damage to DNA.248 However,
production of vitamin D may be optimised, and skin DNA
damage minimised, by increasing the body surface area
exposed, and decreasing the UV-B-dose per unit area.
The World Health Organization’s INTERSUN programme
recommends sun protection when the UV Index is ≥3 and
there have been concerns that there may be little or no vitamin
D production when the UV Index is <3. However, recent com-
putational work suggests that vitamin D could be synthesised
at these lower levels of UV radiation, albeit more slowly.249
Webb and colleagues have shown that for the white-skinned
Table 3 Commonly used cut-oﬀ points for vitamin D status based on serum concentrations of 25(OH)D in nmol L−1
Author Year
Concentration of 25(OH)D in nmol L−1
Deficiency Insuﬃciency Suﬃciency Optimal
Hollis221 2005 >80
U.S. Institute of Medicine222 2010 <30 30–50 ≥50
Pearce and Cheetham223 2010 <25 25–50 50–75 >75
US Endocrine Society224 2011 <50 52.5–72.5 ≥75
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population of Manchester, UK, a normal lifestyle with relatively
short, regular exposures to summer sunlight in northern
mid-latitudes could increase vitamin D enough at the end
of summer to maintain suﬃciency levels (>50 nmol L−1 or
20 ng ml−1) throughout the winter.218,250
Evidence of associations between
vitamin D and human disease
The vital role of 1,25(OH)2D in maintaining the concentration
of calcium in the blood within a narrow range is well-estab-
lished; vitamin D deficiency causes rickets in children and
osteomalacia in adults. In recent years, many protective func-
tions have been attributed to vitamin D. However, two recent
systematic reviews of observational and intervention studies
cast doubt on the importance of vitamin D in decreasing the
risk of many of these diseases.251,252
Immune function, infections, autoimmune diseases and
cancer
Many of the cell types involved in immune function are able to
convert 25(OH)D to the active form, 1,25(OH)2D.
253 The
actions of 1,25(OH)2D are mediated through ligation with a
nuclear vitamin D receptor (VDR) that regulates gene transcrip-
tion, or via rapid-response membrane receptors. The VDR is
expressed in many human cells, including those with immune
functions. Polymorphisms in the VDR can aﬀect the eﬀective-
ness of gene transcription, altering the action of the active
hormone. Immunostimulatory and immunosuppressive path-
ways are induced by 1,25(OH)2D (reviewed in Hewison
254,255
and Christakos et al.255). Immunostimulatory eﬀects include
the production of AMPs such as cathelicidin by macrophages,
neutrophils, and epithelial cells, and the maturation of macro-
phages. Immunosuppressive eﬀects include the inhibition of
proinflammatory cytokines and the diﬀerentiation and matu-
ration of dendritic cells and their ability to present antigens.
Furthermore, 1,25(OH)2D can inhibit the diﬀerentiation and
proliferation of B cells and their production of antibodies, and
activate Treg cells that have suppressor activity. These multiple
eﬀects make it diﬃcult to determine what role, if any, vitamin
D has in protection against disorders of immunity. Studies of
infectious diseases (using tuberculosis and respiratory viral
infections as examples), autoimmune diseases (using multiple
sclerosis as an example), and the risk of cancer incidence and
progression are discussed below.
Vitamin D and tuberculosis. Tuberculosis (TB), a disease
caused by infection with the bacterium Mycobacterium tubercu-
losis, is a massive global health burden, with an estimated
9 million new cases and 1.7 million deaths each year. Infection
can lead to symptomatic active disease or, more commonly, to
a latent infection which can reactivate later in a small pro-
portion of cases. Recent studies suggest an association
between low vitamin D status (or lower ambient UV radiation
as a presumed proxy) and the prevalence of TB (reviewed in
Ralph et al.256), but it is not clear whether low vitamin D status
increases the risk of symptomatic TB or vice versa. A beneficial
eﬀect of vitamin D is plausible through its immune properties,
such as the macrophage-induced death of the M. tubercu-
losis.256 However, vitamin D supplementation as an adjuvant
to standard antimicrobial therapy has shown no clinical
benefit in most studies.257–259 In a trial in Mongolian children,
supplementation with vitamin D stimulated innate immunity
against M. tuberculosis, which could be suﬃcient to prevent
the infectious process.260 Further research using optimal
doses of vitamin D supplementation and with exploration of
the eﬀect of host determinants, such as VDR genotype, are
required to establish whether improving vitamin D status
could aid in the prevention or treatment of TB.
Vitamin D and respiratory infections. Viruses infecting the
respiratory tract and causing disease, such as bronchiolitis
and pneumonia, are a leading cause of hospitalisations and
death in young children, and of serious illness and death in
those over 65 years. Examples include influenza virus, respira-
tory syncytial virus, and rhinovirus. Viral respiratory infections
are most common in winter and least common in summer.
This seasonal pattern is diminished in the tropics where there
is also relatively little seasonal variation in solar UV-B radi-
ation, although there are two peaks of infection in some
countries, perhaps reflecting the rainy seasons.261 It is hypoth-
esised that vitamin D-dependent immunoregulation mediates
these seasonal patterns.262
Recent observational studies typically show that lower
concentrations of 25(OH)D are associated with greater risk of
having a respiratory tract infection (for example263–266).
However, in most cases, study participants had disease symp-
toms when they were first assessed, so that low vitamin D
status could be either a cause or a consequence of the infec-
tion. The results from supplementation trials with vitamin D
are inconsistent, as indicated by the following studies. Separ-
ate trials in Japanese267 and Mongolian268 children showed
reduced incidence of respiratory infection in the sup-
plemented groups, and there is some evidence of benefit in
postmenopausal women,269 young Finnish men270 and older
Australian adults (using antibiotic use as a surrogate for infec-
tion).271 In contrast, trials of supplementation in adults from
the United States272,273 and New Zealand274 failed to show any
beneficial eﬀect of vitamin D.
Reducing the risk of infectious diseases would have signifi-
cant impacts on personal morbidity and global economies;
however, the role of vitamin D in promoting this is unclear at
this time.
Vitamin D and multiple sclerosis. Observational studies
consistently show that higher concentrations of 25(OH)D are
associated with lower risk of MS (reviewed in Hewer et al.197),
and that vitamin D deficiency is associated with decreased
responsiveness to MS treatment, and may be a risk factor for
higher MS disease activity and more rapid progression (for
example, Ascherio et al.275).
Most studies, however, cannot distinguish between cause
and eﬀect; that is, does low vitamin D status cause the disease
or does the disease cause the low vitamin D status? Indeed,
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there is evidence that concentrations of 25(OH)D are reduced
by inflammation.276 Further, a review of randomised controlled
trials of supplementation with vitamin D in people with MS
found no evidence of improvement in clinical endpoints.251
Overall, the authors hypothesised that either uncontrolled con-
founding or reverse causality provided an explanation for the
strong and consistent associations in observational studies
and the lack of eﬀect of supplementation.
It is also important to consider possible heterogeneity in
MS, coupled with a lack of understanding of the timing of the
onset of disease pathology and thus the most appropriate time
to test vitamin D status or to give vitamin D supplementation.
In addition, the risk factors for disease onset may diﬀer from
those of progression.277
Vitamin D and cancer risk. Vitamin D deficiency may
increase the risk of developing cancer as 1,25(OH)2D has regu-
latory eﬀects on cellular growth, apoptosis and formation of
new blood vessels. Observational studies consistently show
associations between low circulating 25(OH)D and increased
risk of colorectal cancer (reviewed in Autier et al.251) but, for
other cancers, there have either been too few studies or the
results are inconsistent.251,252 Trials do not show evidence of
beneficial eﬀects with vitamin D supplementation.278 In
addition to the reasons discussed above for similar discrepant
findings in relation to MS, the null findings from trials with
supplementation of vitamin D may be due to too low a sup-
plement dose, poor compliance, too short a follow-up,
inadequate statistical power of the study, or, parsimoniously,
suggest that vitamin D has no eﬀect.251
It is particularly diﬃcult to assess the eﬀects of vitamin D
on the risk of skin cancer, as UV radiation induces both. Pro-
duction of 1,25(OH)2D in the skin enhances the repair of UV-
induced DNA damage.279,280 Cohort studies have shown protec-
tive281,282 and adverse283 associations between concentrations
of 25(OH)D and risk of NMSC and similar inconsistencies for
the risk of CMM.283,284 Post-hoc analyses of the Women’s
Health Initiative trial did not show a protective eﬀect of sup-
plementation with vitamin D on the risk of NMSC or CMM, but
in people with a history of NMSC, the incidence of CMM was
reduced in those randomised to 400 IU of vitamin D per day.285
In summary, the evidence that higher vitamin D status is
protective for cancer is weak and inconsistent, except possibly
for colorectal cancer risk. If vitamin D deficiency is truly a risk
factor, it is low concentrations of 25(OH)D (i.e., <30 nmol L−1)
that are associated with increased risk with little additional
benefit for concentrations >50 nmol L−1.286
Vitamin D and cancer-survival. Higher vitamin D status has
been positively associated with survival from a number of
diﬀerent cancers,251,287 but there is a paucity of trial data, and
confounding by severity of disease or co-morbidities is highly
likely. At this time there is insuﬃcient evidence to draw any
conclusions.
Eﬀects of vitamin D on other health conditions. Several
studies suggest that maternal vitamin D deficiency is associ-
ated with adverse outcomes in the oﬀspring across multiple
domains: bone mineral content,288 cognitive function,289
depression and risk of eating disorders,290 and autism.289 Fur-
thermore, vitamin D deficiency in early life has been linked to
increased risk of schizophrenia in later life.291 These results
may indicate that vitamin D status during pregnancy is impor-
tant for foetal development, but further research will be
required to confirm whether these are causal associations or
due to a related factor(s).
Prospective studies have reported moderate to strong
inverse correlations between concentrations of 25(OH)D and
cardiovascular diseases, concentrations of serum lipids, inflam-
mation, disorders of glucose metabolism, weight gain, mood
disorders, declining cognitive function, dementia, Alzheimer’s
disease, impaired physical functioning, and mortality. In con-
trast, intervention trials show no eﬀect of vitamin D sup-
plementation on these outcomes.251
U-shaped associations between vitamin D metabolites and
disease
Recent research shows that both high and low concentrations
of 25(OH)D are associated with increased disease risk – a so-
called U-shaped association. Table 4 provides a summary of
studies showing this eﬀect.
An additional U-shaped association has been shown
between concentration of 1,25(OH)2D and viral load in patients
with HIV.306
There is a trend to advocate ever higher cut-oﬀs to denote
the concentration of 25(OH)D concentrations that is optimal
to prevent disease.307 It is therefore important to continue to
investigate possible disease risks at higher concentrations of
25(OH)D, especially if the aim is to maintain such levels over
the long-term.
Other eﬀects of solar UV radiation on
human health
Chronic exposure to UV radiation has been weakly linked to a
range of other adverse health outcomes, including: decreased
Table 4 Health outcomes for which a U-shaped association with
serum 25(OH)D levels has been described, and the 25(OH)D level of
lowest risk
Disease/condition
Concentration (nmol L−1) of
lowest risk, i.e. the turning
point of the U-shaped dose
response
All-cause mortality292–294 80–100
Cardiovascular events295,296 50–100
Cancer mortality297,298 100 (men only)
Prostate cancer299,[300] 50 [≤55 (highest risk, 91–106)]
Pancreatic cancer301 <100
Allergen-specific IgE during
childhood302
50–74.9
Tuberculosis303 76–140
Schizophrenia (neonatal vitamin D
status)291
47
Small-for-gestational-age births
among white women304
60–70
Physical frailty in older women305 50–74.9
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epidermal308 and subcutaneous309 lipid synthesis resulting in
weakening of the barrier function of the skin; hearing impair-
ment, through oxidative stress pathways;310,311 lactase non-
persistence;312 increased risk of prostate cancer;313 and
acquired bilateral nevus-of-Ota-like macule, a common pig-
mentation disorder in Asian females.314
In contrast, there is evidence of a protective eﬀect of higher
UV radiation on development of restless legs syndrome315 and
keloid formation in scars.316 There are a growing number of
studies examining the apparently beneficial eﬀects of exposure
to the sun. A recent study has shown that UV-A irradiation is
eﬀective in lowering blood pressure, possibly through UV-A-
induced nitric oxide bioactivity.317 A reduced risk of cancer
and particularly breast cancer has been reported in association
with greater exposure to the sun in early life,318 as well as a
decreased risk of myocardial infarction, and all-cause mor-
tality, and hip fracture in those below age 90, where history of
skin cancer was the measure of past exposure to the sun.319 In
Chile the most frequent cases of food-related anaphylaxis
(severe allergic reaction) occur at higher latitudes where there
is lower solar radiation.320
Personal protection from solar UV
radiation
The threat of increasing levels of UV-B radiation due to strato-
spheric ozone depletion, and rising skin cancer incidence
rates, led to the development of sun protection programs and
strategies. Despite the partial recovery of the ozone layer
(reviewed in Bais et al.2), such strategies remain important
because changes in climate are likely to alter both ambient UV
radiation and behaviour that aﬀects exposure to the sun.
A sustained eﬀort is required to change attitudes and behav-
iours in relation to exposure to the sun, especially in young
people.321 Several recent surveys indicate that adults,322,323
adolescents,324 and children,325,326 still commonly report
having been sunburned in the previous year, and this applies
to both fair- and dark-skinned populations.327
While in some locations a majority of children use some
form of photoprotection, particularly shade,325,326,328 this is
not true of adults.323 Good knowledge of protection from the
sun may not translate into attitudes and practices for reducing
exposure.326,328,329 Further, more education about the specific
needs for photoprotection in diﬀerent situations may be
required. In a sample of young German children, parental
knowledge of appropriate use of shade, clothing, a sunhat,
and sunscreen was considered to be adequate for summer
holidays at the beach, but not for everyday outdoor activi-
ties.330 In a Danish study, travel to a sunny destination was
common (almost 50% of those aged 15–59 years took such a
holiday each year), with a high likelihood of sunburn and
intentional tanning.331 There are limited data on strategies for
photoprotection in tropical countries but one survey in adoles-
cents living in Bangkok, Thailand, found that sunscreens, sun-
protective clothing, and shade were seldom used, particularly
in males, compared with Western countries.332 In a study in
Philadelphia, USA, Hispanic adolescents and young adults
who showed evidence of greater adoption of US culture were
less likely to use sunscreen and more likely to deliberately
expose themselves to the sun than those who retained their
traditional culture.333 Barriers to personal protection from the
sun in young Australians include peer pressure, lifestyle,
fashion and social norms.334
The ultraviolet index (UVI) is routinely published in the
media in some countries, available online,335 on a mobile
phone,336 on mobile phone apps,337 or can be approximated
using a compact disk as a sundial.338 However, its use to guide
behaviour in relation to exposure to the sun remains
limited.339 Furthermore, the specific guidance in relation to
the UVI varies across diﬀerent countries. For example, in
Australia, photoprotection is recommended when the UV
Index is ≥3.335 In New Zealand, a “UV Sun protection Alert
Period” is provided daily, rather than the UVI, and is defined
as the period of the day where the forecast clear-sky UVI is
>3.340 The United States Environmental Protection Agency pro-
vides a UV Alert when the forecast UVI is ≥6, with advice to
minimise time in the sun and use protection.341 As noted,
exposure to the sun when the UVI is <3 is relatively ineﬀective
for vitamin D production, whereas, for some fair-skinned indi-
viduals, even short exposures at a UVI of 6 may result in
erythema. It is diﬃcult to provide blanket recommendations,
even according to the UVI and skin type, as there is wide vari-
ation in the minimal erythema dose (MED, the dose of UV
radiation required to cause a slight reddening of the skin)
even within a specific skin type, and diﬀerent messages may
be required for diﬀerent regions.69
It is not generally realised that measures for protection
against the sun may be required on cloudy days, in addition to
clear days, due to diﬀuse solar UV radiation,342,343 and that
some shade devices, such as umbrellas, provide incomplete
protection from UV-B radiation.344
Sunscreens
Public health bodies have long advocated the use of sun-
screens as a means of photoprotection. A long-term prospec-
tive study in Queensland, Australia, showed that daily use of
sunscreen reduced the incidence of SCC345 with some evi-
dence of reduction in the incidence of CMM.346 In addition,
such use also reduced photoageing of the skin.347 However, a
recent meta-analysis of the eﬀectiveness of interventions pro-
moting use of sunscreen in adults and children in recreational
settings showed no reduction of sunburn in adults and only a
modest eﬀect in children.348
Sunscreens are formulated and tested for their ability to
prevent erythema in vivo and their index of eﬃcacy is the
sun protection factor (SPF).349 The labelled SPF is equal to:
[MEDprotected skin]/[MEDunprotected skin], when tested under labo-
ratory conditions with simulated solar radiation. The
erythema action spectrum dictates that this is primarily an
index of protection from UV-B radiation, although sunscreens
are also required to have a measure of protection against UV-A
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radiation.350 Sunscreens with uniform absorption across
the whole UV spectrum (broad-spectrum) provide photoprotec-
tion that is similar to shade or some types of clothing fabric351
(for more detail, see Andrady et al.352). Some UV radiation
filters may also have anti-inflammatory properties,353 in which
case the SPF may be more than a measure of optical
filtering.354
One requirement of the SPF test is that sunscreen is
applied at a coverage of 2 mg cm−2, but several studies have
shown that people apply much less (for example, Petersen
et al.355). The thickness of the application is also dependent
on the formulation, with coverage of only 0.22 mg cm−2
achieved by children applying sunscreen with a roll-on.356 Use
of a higher SPF sunscreen or two applications of sunscreen
can achieve a greater level of protection.357,358 In addition to
inadequate thickness of application, failure to apply sunscreen
to all areas of exposed skin also limits the amount of photo-
protection achieved. There are concerns that using sunscreen
will decrease synthesis of vitamin D. Current evidence suggests
that, if sunscreen is correctly applied, there may be no increase
in concentrations of 25(OH)D following exposure to the sun.359
However, with usual applications, there is minimal impair-
ment of the synthesis of vitamin D.282,360
Traditional topical sunscreens depend on the filtering or
scattering of UV radiation, i.e., “passive” photoprotection.
Table 5 summarises some recent developments in compounds
providing “active” photoprotection at a topical and systemic
level.361
Overall, people are probably getting much less protection
from the harmful eﬀects of UV radiation than they believe
when they use sunscreens, especially if their intention is to
prolong their time in the sun. This is a public health issue
that has to be addressed either by encouraging people not to
go outdoors when the UVI is high, or to use appropriate cloth-
ing (see also Andrady et al.352) for sun protection.335 Alterna-
tively, people need to apply sunscreen more thickly, or use
sunscreen of a higher SPF to compensate for inadequate
application.
Clothing and shade
Clothing modifies the skin surface area exposed to solar UV
radiation. It oﬀers good protection against sunburn, although
this is dependent on the properties of the fabric such as
colour, structure (e.g., woven vs. knit and tightness of the
weave for woven fabrics), and wetness (see Andrady et al.352).
Clothing typically strongly attenuates transmission of erythe-
mally-eﬀective UV radiation (i.e., weighted with the erythema
action spectrum) to the skin. However, this blocking of UV-B
radiation commonly leads to low vitamin D status in people
who wear full body clothing,376 for example for religious or cul-
tural reasons.377,378 It may be possible to design and manufac-
ture clothing from fabrics that allows synthesis of vitamin D
while preventing a visible erythema.379 However, it is likely
that this will not protect from suberythemal damage, such as
to the DNA of the epidermal cells.
Shade-seeking is a well-recognised and eﬀective way of
reducing exposure to solar UV radiation, as evidenced by a
lower level of sunburn380 and lower vitamin D status in adults
from the USA who reported frequent use of shade on a sunny
day, compared to those who used shade rarely.360 Provision of
shade over playgrounds, particularly in sunny locations, is a
relatively inexpensive method of mass protection from the sun.
Nevertheless, a systematic review of 23 publications found no
evidence that health promotion interventions had any eﬀect in
increasing shade-seeking in adults or children.348 Shade may
be less eﬀective at reducing exposure to diﬀuse UV radiation
and this may account for about 80% of people’s cumulative
annual erythemal exposure.343 A recent study has used a
manikin head (in a fixed position) to measure exposure to UV
radiation under diﬀerent conditions of shade, cloud cover and
solar angle.381 This approach can be used to quantify the protec-
tive benefits of shade that are currently not well documented.
Preventing skin cancer versus ensuring adequate vitamin D
status
There is no simple message to guide optimal levels of exposure
to the sun. There is considerable variation between individuals
Table 5 Newer active sunscreens and evidence of their eﬀectiveness
Class Route and Eﬀectiveness
α-Melanocyte stimulating hormone analogues – stimulate
melanogenesis (tanning), e.g., afamelanotide
Sub-cutaneous; eﬀective in some photosensitive patients362,363
Natural anti-oxidants, e.g., vitamin A (retinol), vitamin C (ascorbic acid),
vitamin E (tocopherol), pycnogenol (pine bark extract), carotenoids
Oral; not as eﬀective as topical sunscreens361,364
Nicotinamide (an amide form of vitamin B3) Topical; enhances DNA repair, prevents UV-induced
immunosuppression, reduces incidence of NMSC365
Resveratrate, found in red wine, grapes, plums and peanuts Topical; application immediately after exposure to the sun protected
against erythema and sunburn cell formation366
Flavonoids, e.g., luteolin (a) Protects skin by a combination of UV-absorbing, DNA-protective,
antioxidant and anti-inflammatory eﬀects.367
Lycopene, found in tomato paste Oral; ingestion over a 12 week period reduced acute & chronic eﬀects
of photodamage368
Green tea polyphenols Oral; some evidence of modest eﬀect369,370
Diet rich in omega-3 fatty acids Oral; may reduce risk of skin cancer371,372
Liposomes containing natural endonucleases or photolyases Topical; enhance nucleotide excision repair of UV-induced DNA
damage; shown to reduce the incidence of solar keratoses and the
severity of polymorphic light eruption.373–375
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in the doses of UV radiation that cause damage to DNA and
induce synthesis of vitamin D. However, some broad recom-
mendations can be made. Repeated short exposures to the
sun are more eﬃcient at vitamin D production than a single
prolonged exposure.218 Levels of UV-B radiation are greatest at
midday and vitamin D synthesis is thus most eﬃcient at this
time,382 although it is also the time when sunburn occurs
most quickly.383 The amount of time in the sun that is needed
for the synthesis of vitamin D varies according to location,
time of day, and time of year. After controlling for the level of
exposure to UV radiation, having more skin not covered by
clothing is associated with higher concentrations of 25(OH)D
in serum.246,247 As noted above, there are conflicting results on
the eﬀect of darker pigmentation of skin on the UV-induced
production of vitamin D. In high latitude locations where UV-B
levels are too low for vitamin D synthesis and a cooler climate
may mean that little skin is exposed to the sun even during
summer, greater intake of vitamin D may be required to avoid
vitamin D deficiency.
Protection of the eye
One of the cheapest and most practical methods of protecting
the eye from exposure to UV-B radiation is wearing a hat with a
brim of at least 6–7 cm.335,384 Sunglasses provide variable pro-
tection, and standards are more rigorous for UV-B than for
UV-A radiation. For UV-B radiation the upper transmission
limits range from 1.0% to 12.5% depending on the inter-
national jurisdiction and the type of use. For UV-A radiation,
the limit is either a maximum of 50% of visible transmittance
or is unspecified. The size of the frame and design can influ-
ence eye protection and some standards for sunglasses incor-
porate a minimum size limit.385 Wrap-around designs are
most protective and are especially important when in highly
reflective conditions, for example when skiing.385 Many ordi-
nary eye-glass lenses have UV filters in them.
The American National Standards Institute (ANSI) requires
that contact lenses absorb at least 95% of UV-B radiation and
70% of UV-A radiation for a “UV blocking” claim. A recent
survey on a selection of lenses showed compliance with claims
for photoprotection.386
Studies using manikin heads387,388 have shown that,
although the ambient UV radiation is greatest at solar noon,
the highest dose of UV radiation was received by the eye at
4 hours before and after noon, when the solar elevation angle
was lower. Thus, photoprotection of the eyes during outdoor
activities is important not only at noon, but also at other
times, and during winter.389 In some occupations, e.g.,
working on a building site, the reflectivity of the building
materials may influence the amount of UV radiation received
by the eye390 and should be considered when wearing eye-
protection.
Protection of the eyes from the sun should reduce the risk
of pterygium; UV absorbing contact lenses that cover most of
the cornea can protect against UV-induced damage.385,391 Eye
drops for the prevention of pterygium and photokeratitis/
photoconjunctivitis through anti-oxidant and anti-inflamma-
tory pathways have been eﬀective in animal models, but are
not commonly used in humans.119,392
Eﬀects of interactions between solar
UV radiation and the environment
Environmental contaminants may interact synergistically with
UV radiation to harm human health. For example, in the pres-
ence of UV-B radiation, chrysene,393 a common environmental
contaminant produced by incomplete burning of fossil fuels,
and some pesticides394 have adverse eﬀects on human health,
including through damage to DNA.395 Topical corticosteroids
are unstable under UV-B irradiation, possibly causing skin
damage as well as loss of therapeutic eﬀect.396 Engineered
nanoparticles (NPs) are increasingly incorporated into sporting
equipment, sunscreens, clothing and cosmetics (see also
Andrady et al.352). Concerns have been raised about possible
health risks of NPs.397,398 A recent review of the evidence on
NPs in sunscreens concluded that “on current evidence,
neither TiO2 nor ZnO NPs are likely to cause harm when used
as ingredients in sunscreens”.399 Nevertheless, exposure of
skin to UV radiation may enhance the penetration of engi-
neered NPs,400 and the formulations using these particles are
often used around the time of irradiation when skin damage
may occur. Further, UV-induced immunosuppression could
potentially impair an immune protective response induced by
engineered NPs applied to the skin.400
On the positive side, UV radiation is a potent environ-
mental disinfectant able to inactivate viruses in clear water
(for further discussion see Häder et al.401). This property is
used in the SODIS (solar disinfection) technique, where
exposure of surface water within a transparent bottle to sun-
light eﬀectively disinfects the water, decreasing the incidence
of diarrhoeal diseases (reviewed in McGuigan et al.402).
Health implications of interactions
between ozone depletion and climate
change
Past studies have estimated the health gains in terms of skin
cancers avoided through the implementation of the Montreal
Protocol and its amendments.403 A recent update of this work
that also integrated coupled climate-chemistry models has esti-
mated that the world-wide incidence of skin cancer would
have been 14% greater (2 million people) by 2030 without
implementation of the Montreal Protocol and its amend-
ments,404 with the largest eﬀects in the South West USA and in
Australia (see Bais et al.2 for further details).
Model estimates405 suggest that by 2050, any increases in
erythemal UV radiation above present levels will be small and
confined to the tropical region (reviewed in Bais et al.2). These
should have only a small eﬀect on the incidence of skin
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cancer406 but may impair immune responses to some vacci-
nations. However, outside the tropical region, erythemal UV
radiation is projected to be lower, especially in winter
(reviewed Bais et al.2), which could be detrimental for the
vitamin D status of populations in these regions, as well as for
diseases that may be modulated by exposure to UV radiation,
such as some of the autoimmune diseases discussed above.
Estimates of exposure times for erythema and vitamin D syn-
thesis in Europe, taking account of ozone recovery and inter-
actions with diﬀerent concentrations of greenhouse gases
(GHG),406 suggest that there will be very little change in the
exposure time for both endpoints for Southern Europe.
However, an increased exposure time of about 30% for vitamin
D production would be required in a worst case scenario in
Stockholm in spring with high levels of GHGs.406
A major determinant of the received dose of UV radiation is
behaviour in relation to exposure to the sun.407 Ambient
temperature is likely to influence time spent outdoors. In
temperate parts of Australia, the increase in temperature is
likely to increase skin cancer incidence because people will
spend more time outside with less clothing.408,409 However,
with temperature increases in already warm climates, people
will be more likely to stay indoors or to seek shade.229 Warmer
ambient temperatures may have direct physiological eﬀects to
accelerate both skin cancer development410 and vitamin D
production.411
In addition to these direct eﬀects of interactions between
climate change and ozone depletion and/or UV radiation for
human health, there are potential indirect eﬀects that may
become important, but at this stage remain ill-defined.412 Con-
current changes in climate and levels of ambient UV radiation
will influence aquatic and terrestrial ecosystems (see also
Häder et al.401 and Bornman et al.413), which may have conse-
quences for food safety, quality and supply (reviewed in412).
Migration of populations, often with dark skin pigmenta-
tion, from low-lying tropical regions because of rising sea
levels, to higher latitude regions may increase the diseases
associated with vitamin D deficiency.
Higher temperatures should foster microbial growth in
surface waters, and this will be more pronounced in the pres-
ence of lower levels of disinfecting UV-B radiation, or where
increases in colour due to dissolved organic matter limit pene-
tration of UV-B radiation (for more detail, see Häder et al.,401
Bornman et al.,413 and Erickson et al.414). However, there has
been little research to date that allows prediction or quantifi-
cation of the risks to human health that might arise from
these interactions.
Gaps in our knowledge
Considerable evidence from animal models suggests that UV-
induced immunosuppression may increase the risk of some
infections and decrease the protection oﬀered by vaccination
(reviewed in Norval & Halliday212). Studies in humans are
required to determine whether any increased risk is clinically
relevant, for example, requiring changes in vaccination proto-
cols. Although some animal studies similarly suggest that
vitamin D status aﬀects the outcomes of vaccination or
immune responses to infection, results from clinical trials
mostly show no eﬀect.415,416
There is currently considerable controversy about which
health conditions are influenced by vitamin D. Large-scale
vitamin D supplementation trials that are in progress will
provide some answers (see Table 1 in Byrne417). While there is
consensus that vitamin D is important for bone health, there
is lack of agreement about the concentration of 25(OH)D
required. In addition, there is substantial individual variability
in the change in concentration in 25(OH)D in response to UV
irradiation and vitamin D supplementation, and in the clinical
eﬀects associated with diﬀerent concentrations of 25(OH)D.
The reasons for this are poorly understood, but are likely to
depend on variation in the genes encoding the vitamin D
binding protein and/or the vitamin D receptor.
Production of vitamin D occurs readily at sub-erythemal
doses, but repeated sub-erythemal exposures can also cause
accumulation of CPDs that repair only slowly (over
24–36 hours) and thus may increase the risk of skin cancer.418
Until there is a better understanding of the numbers of CPDs
that accrue during brief sun exposures, and their importance
in determining the risk of subsequent skin cancer, it is
diﬃcult to recommend safe exposures that would result in
suﬃcient production of vitamin D.
There is a lack of data on the vitamin D status of infants,
children, and adolescents and for populations in Africa and
South America. Further, the lack, until recently, of accurate
and precise assays has limited our ability to examine variability
in vitamin D status across countries (for example those with
and without fortification of food) and over time. The advent of
the standardised vitamin D assays419 means that this is now
possible. Development of a less invasive sampling method, for
example using saliva, would allow more widespread assess-
ment of the vitamin D status of infants and children.
Protection from the sun is currently recommended by the
World Health Organization when the UVI is ≥3. The corollary
of this message is that photoprotection is not required when
the UVI is <3. At these low UVI values, there is little UV-B
radiation (and thus little vitamin D synthesis), but, with pro-
longed exposure, there may be a relatively high dose of UV-A
radiation. With recognition that UV-A radiation can induce
immune suppression164 and is involved in the initiation of
CMM, but may also have beneficial eﬀects on blood pressure,
the doses received and potential health eﬀects need to be
better defined.
The action spectra for a number of health outcomes have
not been determined. These include cataract from protracted
exposure, myopia, carcinoma in deeply pigmented skin, mela-
noma and production of pre-vitamin D from a polychromatic
source (the sun) and in both dark and fair skin types.
However, the relevance of the currently available animal
models is uncertain, so obtaining these action spectra with
definite relevance to humans is very diﬃcult.
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There is emerging evidence that exposure to the sun may
have beneficial eﬀects independently of vitamin D. The lack of
a strong evidence-base challenges our ability to provide accu-
rate guidance to the public regarding exposure to the sun.
As noted above, there is much uncertainty about the eﬀect
of the potential indirect interactions of climate change and
ozone depletion on human health. Eﬀects on disinfection of
surface water and on supply and security of food could become
important sources of risks to health, particularly in some
regions of the world. Modelling now may be able to identify
those areas at greatest risk, and allow forward planning to
mitigate the risks.
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